These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38936936)

  • 1. Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice.
    Wang Q; Duan J; Hong J; Ding K; Tai F; Zhu J; Fu H; Zheng X; Ge C
    In Vivo; 2024; 38(4):1636-1648. PubMed ID: 38936936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBLB502, a Toll-like receptor 5 agonist, offers protection against radiation-induced male reproductive system damage in mice.
    Bai H; Sun F; Yang G; Wang L; Zhang Q; Zhang Q; Zhan Y; Chen J; Yu M; Li C; Yin R; Yang X; Ge C
    Biol Reprod; 2019 Jan; 100(1):281-291. PubMed ID: 30084935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.
    Burdelya LG; Brackett CM; Kojouharov B; Gitlin II; Leonova KI; Gleiberman AS; Aygun-Sunar S; Veith J; Johnson C; Haderski GJ; Stanhope-Baker P; Allamaneni S; Skitzki J; Zeng M; Martsen E; Medvedev A; Scheblyakov D; Artemicheva NM; Logunov DY; Gintsburg AL; Naroditsky BS; Makarov SS; Gudkov AV
    Proc Natl Acad Sci U S A; 2013 May; 110(20):E1857-66. PubMed ID: 23630282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy.
    Burdelya LG; Gleiberman AS; Toshkov I; Aygun-Sunar S; Bapardekar M; Manderscheid-Kern P; Bellnier D; Krivokrysenko VI; Feinstein E; Gudkov AV
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):228-34. PubMed ID: 22000579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 5 agonist CBLB502 induces radioprotective effects in vitro.
    Shi T; Li L; Zhou G; Wang C; Chen X; Zhang R; Xu J; Lu X; Jiang H; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):487-495. PubMed ID: 28407032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models.
    Burdelya LG; Krivokrysenko VI; Tallant TC; Strom E; Gleiberman AS; Gupta D; Kurnasov OV; Fort FL; Osterman AL; Didonato JA; Feinstein E; Gudkov AV
    Science; 2008 Apr; 320(5873):226-30. PubMed ID: 18403709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like Receptor Agonist CBLB502 Protects Against Cisplatin-induced Liver and Kidney Damage in Mice.
    Niu P; Zhao W; Wang Q; Duan J; Zhu J; Fu H; Wu Y; Zheng X; Zhang D; Ge C
    In Vivo; 2023; 37(5):2044-2056. PubMed ID: 37652484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury.
    Melin N; Sánchez-Taltavull D; Fahrner R; Keogh A; Dosch M; Büchi I; Zimmer Y; Medová M; Beldi G; Aebersold DM; Candinas D; Stroka D
    Cell Death Dis; 2021 Apr; 12(4):366. PubMed ID: 33824326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors and radiation protection.
    Liu Z; Lei X; Li X; Cai JM; Gao F; Yang YY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):31-39. PubMed ID: 29364499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBLB502, an agonist of Toll-like receptor 5, has antioxidant and scavenging free radicals activities in vitro.
    Li W; Ge C; Yang L; Wang R; Lu Y; Gao Y; Li Z; Wu Y; Zheng X; Wang Z; Zhang C
    Int J Biol Macromol; 2016 Jan; 82():97-103. PubMed ID: 26476243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRC4 Mutation in flagellin-derived peptide CBLB502 ligand-binding domain reduces the inflammatory response but not radioprotective activity.
    Lai L; Yang G; Yao X; Wang L; Zhan Y; Yu M; Yin R; Li C; Yang X; Ge C
    J Radiat Res; 2019 Nov; 60(6):780-785. PubMed ID: 31599956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
    Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
    Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 5 agonism protects mice from radiation pneumonitis and pulmonary fibrosis.
    Wang ZD; Qiao YL; Tian XF; Zhang XQ; Zhou SX; Liu HX; Chen Y
    Asian Pac J Cancer Prev; 2012; 13(9):4763-7. PubMed ID: 23167416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity.
    Leigh ND; Bian G; Ding X; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
    PLoS One; 2014; 9(1):e85587. PubMed ID: 24454895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TLR5 agonist inhibits acute renal ischemic failure.
    Fukuzawa N; Petro M; Baldwin WM; Gudkov AV; Fairchild RL
    J Immunol; 2011 Oct; 187(7):3831-9. PubMed ID: 21890657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FG-4592 protects the intestine from irradiation-induced injury by targeting the TLR4 signaling pathway.
    Feng Z; Xu Q; He X; Wang Y; Fang L; Zhao J; Cheng Y; Liu C; Du J; Cai J
    Stem Cell Res Ther; 2022 Jun; 13(1):271. PubMed ID: 35729656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of TRIF protein in regulating the proliferation and antigen presentation ability of myeloid dendritic cells through the ERK1/2 signaling pathway in chronic low-grade inflammation of intestinal mucosa mediated by flagellin-TLR5 complex signal.
    Zhuang Z; Chen Y; Zheng J; Chen S
    PeerJ; 2024; 12():e16716. PubMed ID: 38188180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.
    Ding X; Bian G; Leigh ND; Qiu J; McCarthy PL; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
    J Immunol; 2012 Nov; 189(10):4719-27. PubMed ID: 23045613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells.
    van Aubel RA; Keestra AM; Krooshoop DJ; van Eden W; van Putten JP
    Mol Immunol; 2007 Jul; 44(15):3702-14. PubMed ID: 17493681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-formylmethionine-leucyl-phenylalanine protects against irradiation-induced damage to hematopoiesis and intestines.
    Li Z; Wu Y; Du J; Qian W; Wang S; Li F; Dong S; Jiao S
    Mol Med; 2024 Sep; 30(1):145. PubMed ID: 39256638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.